References
- Mislow K. Introduction to Stereochemistry. Benjamin, New York 1966
- Liu S.-T., Hurwitz A. Effect of enantiomeric purity on solubility determination of dexclamol hydrochloride. J. Pharm. Sci. 1978; 67: 636–638
- Yalkowsky S. Techniques of Solubilization of Drugs. Marcel Dekker, Inc., New York 1981; 170
- Repta A. J., Baltezor M. J., Bansal P. C. Utilization of an enantiomer as a solution to a pharmaceutical problem: application to solubilization of 1,2-di(4-piper-azine-2,6-dione)propane. J. Pharm. Sci. 1976; 65: 238–242
- Doerge R. D., Daniels T. C., Jorgensen E. C. Textbook of Organic, Medicinal and Pharmaceutical Chemistry6th ed., C. O. Wilson, O. Gisvold, R. D. Doerge. Lippincott, Philadelphia 1971; 31–33
- Andrews P. Praziquantel: mechanisms of anti-schisto-soma1 activity. Pharmacol. Ther. 1985; 29: 129–56
- Andrews P., Thomas H., Pohlke R., Seubert J. Praziquantel. Med. Res. Rev. 1983; 3: 147–200
- Lin Y. H., Qian M. X., Wang X. G., Jia J., Wang Q. N., Jiang Y. F., Wang R. Q., Yan S. H., Chen B. Y., Li J. S., Qui Z. Y., Shen J. K. Comparative efficacy of praziquantel and its optic isomers in experimental therapy of Schistosoma japonicum in rabbits. Chin. Med. J. 1986; 99: 935–940
- Xiao S. H., Catto B. A. Comparative in vitro and in vivo activity of racemic praziqunatel and its levorotated isomer on Schistosoma mansoni. J. Inf. Dis. 1989; 159: 589–592
- Bricker C. S., Depenbusch J. W., Bennett J. L., Thompson D. P. The relationship between tegumental disruption and muscle contraction in Schistosoma mansoni exposed to various compounds. Zeitsch. Parasitenkunde 1983; 69: 61–71
- Wang X. G., Liu Y. H., Qian M. X., Yan S. H., Cheng B. Y., Wang Q. N., Zheng X. P., Jin J. M., Zhang G. S., Long J. S., Wang T., Huang T., Xue G. J. Comparative efficacy of levopraziquantel and praziquantel in the treatment of Schistosoma japonicum infection. Acta Chongqing Med. Univ. 1987; 12: 9–12, in Chinese; English abstract
- El-Arini S. K., Leuenberger H. Dissolution properties of praziquantel-β-cyclodextrin systems. Pharm. Dev. Technol. 1996; 1: 307–315
- Higuchi T., Connors K. A. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 1965; 4: 117–212
- Prankerd R. J., Ahmed S. M. Physicochemical interactions of praziquantel, oxamniquine and tablet excipients. J. Pharm. Pharmacol. 1992; 44: 259–261
- United States Pharmacopeia. National Formulary 1823rd ed. The United States Pharmacopeial Convention, Rockville, MD 1995; 1274
- The Merck Index11th ed. Merck and Co. Inc., Rahway, NJ 1989, No. 7714
- Burger A., Koller K. T., Schiermeier W. M. RS-Ibuprofen and S-Ibuprofen (Dexibuprofen)-Binary system and unusual solubility behavior. Eur. J. Pharm. Biopharm. 1996; 43: 142–147